The establishment and persistence of many chronic infections have been demonstrated to depend on restraint of the vigor of the anti-microbial immune responses by CD4 1 CD25 1 regulatory T (Treg) cells.
Introduction
Persistent HIV infection is characterized by a slow, progressive depletion of CD4 + T cells and increasing immune dysfunction (1) (2) (3) (4) . Persistence of HIV is associated with impaired anti-HIV immune responses, as well as many other factors. HIV-specific immune responses become impaired early after infection, even before the loss of responses directed against other antigens (5, 6) . HIV-specific CD4 + T cell proliferation is undetectable soon after primary infection (7) . Decreased cytolytic function, inappropriate maturation and limited proliferation have been associated with the inability of CD8 + T cells to control chronic viral replication, although HIV-specific CD8 + T cell responses play an important role in limiting acute viral spread (8) . The molecular basis for such impaired responses has not been elucidated fully, and it is likely that multiple mechanisms, including both HIV-specific and non-specific, are involved (9) (10) (11) . In this regard, the roles of host-mediated immunosuppressive mechanisms activated in the face of persistent HIV replication have not been well delineated. CD4 + CD25 + regulatory T (Treg) cells, a subset of CD4 + lymphocytes with constitutive immunosuppressive activity, were first described in the context of autoimmune disorders (12, 13) . Treg cells have been grossly grouped into natural and adaptive, based on their development, antigenic specificity, mechanisms of action and dependence on TCR and co-stimulatory signaling (14, 15) . CD4 + CD25 + Treg cells are capable of recognizing self-antigens in autoimmune disorders and non-self-antigens in infectious diseases and restrain inappropriate or excessive immune activation (16, 17) . Phenotypically, CD4
+ CD25 + Treg cells have been characterized as expressing CD25 (12) , , glucocorticoidinduced tumor necrosis factor receptor (GITR) (19) , CD86 (20) and the most specific marker identified so far, FoxP3 (a transcription factor) (21) . They also harbor high levels of cyclic adenosine monophosphate (cAMP) (22) . However, it is less clear what the precise roles are of these molecules in CD4
+ CD25 + Treg cell function, although cAMP was reported as a key component of Treg-mediated suppression (17, 22) . The establishment and persistence of many chronic infections have been recently demonstrated to depend on restraint of the vigor of the anti-microbial immune responses by CD4 +
CD25
+ Treg cells (23) (24) (25) . Similarly, CD4 + CD25 + Treg cells have been implicated in potential suppression of HIV-specific CD4 + and CD8 + T cell responses in HIV-infected individuals (26) (27) (28) . In addition, chronic HIV infection changes CD4
+ CD25 + Treg cell tissue distribution with a marked increase of CD4 + CD25 + Treg cells in peripheral lymph nodes (LNs) and mucosal lymphoid tissues, where most HIV replication occurs (29-31). Taken together, these studies suggest that CD4 + CD25 + Treg cells could play a major role in the induction/maintenance of an environment that would favor HIV survival and persistence by impairing protective immune responses (26) (27) (28) (29) . 
cells increased in LNs and duodenal mucosa of HIV
+ subjects and there was increased expression of Treg-associated functional markers in total CD4 + cells, respectively. In addition, it was reported that the activity of Treg cells from LNs was better in comparison to peripheral blood (33). However, the mechanisms underlying the accumulation and altered activity of Treg in LNs and mucosal lymphoid tissues (e.g. distribution altered, new Treg cells induced or existing Treg cells become long lived or expanded) are not clear. The present study presents evidence that HIV direct binding to CD4 + CD25 + Treg cells enhances their function, survival abilities and their rates of homing to peripheral LNs and mucosal lymphoid tissues, and thereby explains the accumulation of Treg cells in lymphoid tissues that are intensified in their function in HIV-infected subjects.
Materials and methods

Mice
Female scid mice (allele: Prkdc scid ) were purchased from the Jackson Laboratories and housed under specific pathogen-free conditions and used for experiment at 6 weeks of age according to protocols approved by the Animal Care and Use Committee of the University of Texas Medical Branch (Galveston, TX, USA).
Flow cytometry
Phenotypes of T cells were analyzed on a FACS Scan instrument (BD Bioscience, San Diego, CA, USA). FITC-or PEconjugated mAbs specific for CD25, CD69, CD38, CD44, CD62L, CLA, CD49d (a4, GeneTex, Inc., San Antonio, TX, USA), b7, GITR, surface CTLA-4 (sCTLA-4), Bcl-2, Bcl-x, FoxP3 (Clone: hFOXY or PCH101, eBioscience, San Diego, CA, USA) and TRAIL were used. FITC-or PE-labeled mouse IgG1, IgG2a and IgG2b isotype controls were applied as needed. Unless specified, all mAbs were obtained from BD Biosciences.
Purification of CD4
+ CD25 + T cells
Blood was obtained from HIV-negative healthy human volunteers or from buffy coats (Gulf Coast Regional Blood Center, Houston, TX, USA). PBMC were isolated from heparinized venous blood by centrifugation through Lymphocyte Separation Medium (Mediatech Inc., Herndon, VA, USA) and washed twice with PBS. Conventional CD4 + T cells were purified from PBMC by negative selection using magnetic beads (Dynal, Lake Success, NY, USA). Briefly, PBMC were incubated with appropriate amounts of antibody cocktail (anti-CD14, anti-CD8, anti-CD19, anti-CD56 and antiglycophorin A) for 30 min on ice. After incubation with goat anti-mouse IgG (GAM)-coated beads for 30 min at room temperature with gentle shaking, the cells were recovered after the magnetic bead-positive cells were removed using a magnetic separator. Subsequently, CD4
+
CD25
+ T subpopulations were obtained by positive selection using anti-CD25-coupled magnetic beads (Dynal 
+ T cells were exposed overnight to HIV-1 213 or HIV-1 BaL at a multiplicity of infection (MOI) equal to 1 in the presence of recombinant IL-2 (10 U ml À1 ). They were then washed and further cultured for indicated experiments unless specified. Recombinant IL-2 was required in the culture of CD4 +
+ T cells since they would lose their suppressive ability if cultured in vitro for >3 days in the absence of IL-2 (data not shown). In some experiments, HIV-1 213 and HIV-1 BaL were UV inactivated before infection as described (35). UV-inactivated virus was tested for its ability to productively infect cells and was found to be unable to replicate. CD4 + CD25 À or CD4 + CD25 + T cells exposed to UV-inactivated HIV were also checked by PCR for HIV-1 gag region and p24 ELISA (Beckman Coulter Inc., Fullerton, CA, USA) as described (36).
Cross-linking (XL) of CD4 (XLCD4), CD62L (XLCD62L) or a4b7 (XLa4b7)
Cells were incubated with mouse anti-human CD4 mAb (clone: RPA-T4), mouse anti-human CD62L (clone: Dreg56) and mouse anti-human a4 mAb (clone: 9F10) plus rat antihuman b7 mAb (clone: FIB504) (2 lg 10 À6 cells) for 30 min on ice, respectively. After three washes, cells were cultured in 96-well plates coated with GAM or GAM plus goat anti-rat IgG (Sigma, St Louis, MO, USA). For the coating of GAM, or GAM plus goat anti-rat IgG to the plates, 50 ll of antibodies in coating buffer (50 lg ml À1 in 30 mmol l À1 NaHCO 3 , 15 mmol l À1 Na 2 CO 3 , pH 9.6) were added to each well, incubated at 4°C overnight and washed five times with PBS. XLCD4 was also performed by plate-coated native gp160 from HIV-1 213 as described (36). HIV-1 213 gp160 was purified using affinity chromatography from SF-9 cells infected with gp160-expressing baculovirus by Bio-Molecular Tech., Inc. (Frederick, MD, USA).
Assessment of cell death and survival
Cells were cultured for 3 days in medium only or in the presence of recombinant IL-2 with or without anti-CD3 antibody. Cells were harvested and viable cells were counted by Trypan Blue exclusion in triplicate samples. Results were expressed as percentage of recovered viable cells at day 3 relative to day 0. In some experiments, cells undergoing apoptosis were detected by annexin V-PE staining, and necrotic cells were determined by 7-aminoactinomycin D (7-AAD) staining according to protocols provided by BD Biosciences. Apoptotic cells were gated on annexin V+ 7-AAD cells. À T cells at 24 h. The levels of IL-2 in the supernatants were determined by specific ELISA using paired mAbs for IL-2 along with the appropriate cytokine controls.
Determination of FoxP3 expression
Total RNA was extracted from cells using RNeasy Mini kit (Qiagen, Valencia, CA, USA) according to the manufacturer's manual. Both cDNA synthesis and PCR amplification were performed using SuperScriptTM III One-step reverse transcription (RT)-PCR kit (Invitrogen, Carlsbad, CA, USA) and gene-specific primers as following:
FoxP3: 5#-GAAACAGCACATTCCCAGAGTTC-3# and 5#-ATGGCCCAGCGG ATGAG-3#, GAPDH: 5#-CCACATCG-CTCAGACACCAT-3# and 5#-GGCAACAAT ATCCACTTTACC-AGAGT-3#. The quantity of mRNA was determined based on the signal densities as determined with an AlphaImager 2200 optical densitometer (Alpha Innotech Corporation, San Leandro, CA, USA). Sample loading was normalized to the amount of the housekeeping gene coding for GAPDH.
Homing assay
The in vitro expanded CD4
+ Treg cells were labeled with 51 Cr as described previously (37). Then, these cells were transferred intravenously into scid mice (1 3 10 7 cells per mouse). Three and 15 h post-transfer, mice were sacrificed and superficial inguinal LNs, GALT and spleen were collected. Radioactivity was determined on a gamma counter (Beckman Coulter, Inc.).
Statistical analysis
Differences between experimental groups were examined using the Student's t-test. A difference in mean values was considered significant when the P value was <0.05 or very significant when the P value was <0.01.
Results
Resting CD4 + CD25 + T cells exposed to HIV-1 resulted in abortive infection
Previous studies have shown that resting CD4 + lymphocytes exposed to HIV resulted in abortive infection, in which the virus binds, enters and partially or completely reverse transcribes proviral DNA, but this DNA does not integrate. Rather, HIV replicates in activated T cells, leading to production of progeny viruses (productive infection) (38-40 
CD25
À cells were exposed to HIV-1 213 or HIV-1 BaL at a MOI equal to 1 as described in Methods. Cell lines H-9 and VB cells were exposed to HIV-1 213 or HIV-1 BaL (MOI: 1), respectively. Supernatants from the cell cultures were collected at day 3 and day 5 and the level of HIV p24 (ng ml À1 ) was measured by ELISA. The sensitivity of HIV p24 ELISA was 8 pg ml À1 ('-' indicates p24-undetectable). Results represent the mean 6 SD of three independent assessments. exposure significantly enhanced the expression of Tregassociated functional markers even at MOI equal to 0.25 ( Fig. 1D) , although the effect was more pronounced at higher MOIs. The expressions of sCTLA4, GITR and FoxP3 were barely detected in CD4 + CD25 À T cells exposed to either HIV-1 or mock control (Fig. 1C) . Interestingly, HIV-1 exposure induced increased levels of CD25 expression on CD4 +
À T cells (Fig. 1C) T cells: MFI: 55 6 4, P < 0.01). In contrast, comparable expression of CD25 was found on HIV-1-exposed CD4 + CD25 + T cells and mock control (Fig. 1B) . As shown in Table 2 , CD4 + CD25 + T cells expressed extremely low levels of the activation markers CD38, HLA-DR or CD69, and HIV-1 exposure had no effect on the expression of these molecules on these cells. However, HIV-1-exposed CD4 + CD25 À T cells expressed higher levels of CD38 and HLA-DR as compared with those of mock controls on day 3 ( Table 2 ). HIV-1-exposed CD4
+ CD25 À T cells also displayed transient increases of CD69 expression on day 1 (Table 2) , which returned to normal levels by day 2-3 (data not shown). As shown in Fig. 2(A and B) , RT-PCR data confirmed that HIV-1 exposure significantly enhanced the expression of FoxP3 mRNA in CD4 + CD25 + T cells (P < 0.01), although FoxP3 mRNA was not detectable in CD4 + CD25 À T cells either exposed to HIV-1 or not.
HIV-1 exposure enhances survival of CD4 + CD25 + T cells
Human anergic/suppressive CD4 + CD25 + Treg cells are thought to be a highly differentiated and an apoptosis-prone population (46) . Therefore, we asked whether HIV-1 infection would impact the survival of CD4 + CD25 + T cells. Fig. 3 (A and B) showed that after 3 days of culture, there was not a significantly lower recovery of live cells in HIV-1-exposed CD4 +
CD25
+ T cells as compared with mock controls. In addition, HIV-1-exposed CD4 + CD25 + T cells did not display significant activation-induced apoptosis (data not shown). Rather, we found that in the presence of IL-2, HIV-1 exposure increased live-cell recovery significantly, regardless of the presence of anti-CD3 mAb. Of note, CD4 + CD25 + T cells did not proliferate after HIV-1 exposure, even in the presence of anti-CD3 mAb. Under the same conditions, IL-2 supplement resulted in vigorous proliferation of CD4 + CD25 + T cells; however, there was no difference between HIV-1 exposure and mock controls after adding anti-CD3 and IL-2 ( Fig. 3C) . These results suggest that HIV-1 exposure increases the survival of CD4 + CD25 + T cells, but not through stimulating proliferation. However, in the presence of IL-2, HIV-1 exposure did not significantly alter live-cell recovery of CD4 + CD25 À T cells (Fig. 3D ) but did significantly decreased the recovery of live CD4 + CD25 À T cells after anti-CD3 stimulation (Fig. 3E) . Decreased survival of CD4 + CD25 À T cells was associated with their proliferation stimulated by the anti-CD3 and IL-2 (Fig. 3F) . Furthermore, flow cytometric analyses showed that IL-2 supplement increased Bcl-2 expression (IL-2: MFI = 168 6 13; control: MFI = 105 6 9, P < 0.05), and HIV-1 exposure significantly enhanced Bcl-2 expression in the presence of IL-2. These results suggest that HIV-1 enhances the survival of CD4
+ CD25 + T cells by synergizing with IL-2 to up-regulate the anti-apoptotic molecule Bcl-2. However, HIV-1 exposure did not show any impact on the expression of Bcl-x and TRAIL (Fig. 3G) . Fig. 4(A) , HIV-1 binding increased the expression of homing receptors CD62L and a4b7, but not that of CLA (Fig. 4A) . Furthermore, HIV-1 exposure enhanced the homing of CD4 + CD25 + T cells to peripheral LNs (at 3 and 15 h) and to mucosal LNs and tissues (at 15 h) in vivo (Table 3) . 
À cells were exposed to HIV-1 213 or mock controls as described in Methods. Cells were harvested at 1 day (CD69) or three days (CD38 and HLA-DR) and stained for the indicated surface activation markers. The percentage of positive cells is shown. Results represent the mean 6 SD of three independent assessments. Asterisks indicate a statistically significant difference (*P < 0.05, **P < 0.01) as compared with the mock controls. 
+ and CD4
+
CD25
À T cells, respectively, and RT-PCR amplification was performed as described in Methods. Results of a representative assay are shown (A). Quantities of FoxP3 mRNA detected was normalized and expressed relative to the amount of GAPDH and representative analysis out of three independent assessments is shown (B). Asterisks indicate a statistically significant difference (**P < 0.01) compared with any other controls.
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In this study, we also found that cross-linking integrin a4b7 on HIV-1-exposed regular CD4 + CD25 À T cells in vitro induced apoptosis (Fig. 4B and C) . However, cross-linking of the homing receptors CD62L or integrin a4b7 on HIV-1-exposed CD4
+ CD25 + T cells in vitro did not induce such apoptosis ( Fig. 4B and C) . Thus, if homing-induced apoptosis of HIV-signaled normal resting CD4 + T lymphocytes is an important mechanism of depletion (47-49), then that HIVexposed Treg cells may not die after homing would clearly exacerbate the immune dysfunction occurring in HIVinfected people.
Exposure of CD4
+ CD25 + T cells to HIV-1 also enhances their suppressive abilities Next, we investigated whether HIV-1 binding affects the effector functions of CD4
+ T cells. We assessed the Cr, cells were injected intravenously into scid mice (1 3 10 7 cells per mouse, five mice per group). Mice were sacrificed at indicated time points of post-transfer, and peripheral (superficial inguinal) lymph nodes (PLN), mesenteric lymph nodes (MLN), duodenum and spleen were collected. Radioactivity was determined on a gamma counter and is presented as c.p.m. Asterisks indicate a statistically significant difference (*P < 0.05, **P < 0.01) as compared with the mock controls. + CD25 + T cells, showed a vigorous proliferative response that was inhibited up to 62% at a 1:1 ratio upon co-culture of the two cell populations (Fig. 5A) . However, exposure to HIV-1 (either HIV-1 213 or HIV-1 BaL ) resulted in even higher levels of suppressive activity (up to 2-to 5-fold) (Fig.  5A) . As expected, CD4
+ CD25 + T cell suppressive function enhanced by HIV-1 is not IL-10-or TGF-b-dependent because neither anti-IL-10 and/or anti-TGF-b could block it, although HIV-1 exposure increased IL-10 production by CD4 + CD25 + T cells (data not shown). It has been demonstrated that HIV-1 or some of its components could reduce IL-2 production and survival (50) and inhibit proliferation (51) of CD4 T cells. To test whether the residual virus or its components on the surface of CD4 + CD25 + T cells directly contribute to the inhibited proliferation of autologous CD4 + CD25 À T cells in our experiments, we conducted the experiments using HIV-1-exposed CD4 + CD25 À T cells, we measured IL-2 production in the co-culture supernatant. As shown in Fig. 5(C) , culture supernatants from either HIV-1 213 -or HIV-1 BaL -exposed CD4 + CD25 + T cells co-cultured with CD4 + CD25 À T cells contained lower levels of IL-2 over the ratios of 1:4 through 1:32 than those of mock-treated CD4 + CD25 + and CD4 + CD25 À T cell co-cultures. These results suggest that HIV-1 binding enhances the Treg function of interferring with the IL-2 production in target cells.
Involvement of HIV gp120-CD4 interaction in increased FoxP3 expression
To determine whether HIV gp120 binding to CD4, per se, was involved in inducing increased FoxP3 expression, we added soluble recombinant CD4 (sCD4) before HIV-1 exposure of CD4 + CD25 + T cells and found that sCD4 almost completely abrogated HIV-1 213 -or HIV-1 BaL -mediated increases in FoxP3 expression (Fig. 6A) . Then, experiments examining CD4 signaling alone were performed. XLCD4 with anti-CD4 mAb and goat anti-mouse IgG or with plate-coated gp160 on the CD4 +
CD25
+ T cells resulted in higher expression of FoxP3 (Fig. 6A) . However, anti-CD4 mAb alone without cross-linking could not alter the expression of FoxP3 (data not shown). These results suggest that CD4 cross-linking, per se, is required to induce FoxP3 up-regulation. XLCD4 either with anti-CD4 mAb plus GAM or with plate-coated gp160 on the CD4 + CD25 + T cells also enhanced their suppressive activity and survival ( Fig. 6B and C) . Finally, as shown in Fig. 6 (A-C) UV-inactivated HIV-1 213 or HIV-1 BaL had the same effects on FoxP3 expression, survival and suppressive activities of CD4 +
+ T cells as live viruses. All these data demonstrate that HIV-1 induces enhanced suppressive properties and other changes of CD4 + CD25 + T cells via HIV gp120 binding to CD4 molecules and that active virus replication is not required.
Discussion
Here, we provide evidence that HIV-1 binding to CD4 directly enhances CD4
+ CD25 + Treg cell suppressive function, ]thymidine was added 18 h before harvest and incorporated radioactivity was determined on a beta emission reader. (C) Supernatants were collected at 24 h and levels of IL-2 were determined by ELISA. All data are presented as means 6 SD of triplicate wells. One of three independent experiments is shown. Asterisks indicate a statistically significant difference (*P < 0.05, **P < 0.01) compared with any other controls. + CD25 + cells, which is accompanied by increased Bcl-2 expression (Fig. 3A, B and G) . In addition, the increased levels of TGF-b found in HIV + patients could also promote Treg survival in vivo (62) . FoxP3 over-expression in HEK293T and purified CD4 + T cells results in suppression of HIV-1 promoter transcription (63) . Therefore, limiting HIV-1 transcription by increased FoxP3 in HIV-1-infected Treg cells may be one of the mechanisms for Treg cells to avoid HIV-1 replication-mediated cell death in vivo. Furthermore, CD4
+ CD25 + cells are not susceptible to activation-induced apoptosis (46) , and such a phenotype may be responsible for the inability of HIV-1 binding to induce the expression of regular T-cell activation markers such as CD69, CD38 and HLA-DR on these cells.
In previous studies, we demonstrated that cross-linking of the homing receptor CD62L on HIV-1-exposed resting (e.g. (Fig. 4 and Table 3 ). Taken together, it appears that HIV-1 cannot induce the death of CD4 + CD25 + Treg cells directly or indirectly, and thus this mechanism cannot explain the observed decrease in Treg cells in the peripheral blood. Rather, it is likely that their decrease in peripheral blood reflects their accelerated exit and re-distribution to LNs and gut, rather than an overall decrease. In support of this, the number of Treg cells is greatly increased in peripheral LNs (29, 30) and mucosal lymphoid organs (31), while they are decreased in the circulating T cell pool in HIV-infected people (29). It should be recognized, however, that although several groups have reported a decrease in CD4 + CD25 + Treg cells in the peripheral blood of HIV patients (29, 32, 61), other groups demonstrated that a slight elevation in CD4 + CD25 + Treg cells occurred in the circulating T cell pool (28, 31). One explanation may be the difference in selection of Treg-associated functional markers and/or the variation of selected HIVinfected subjects. Another explanation is that in the peripheral blood of advanced HIV patients, the relative proportion of Treg cells is probably elevated because of the depletion of non-Treg CD4
+ cells, although their absolute number is not increased (31).
It is possible that in HIV + patients, increases in cells having Treg-associated functional markers FoxP3, sCTLA-4 and GITR may also derive from the presence of activated nonTreg cells since these molecules can be up-regulated briefly during antigen activation of non-Treg cells (64, 65) . However, results from our and other's studies do not favor this possibility because increased expression of these molecules was 
CD25
+ cells were exposed to HIV-1 with or without sCD4, UV-inactivated HIV-1, anti-CD4 plus GAM or plated-coated gp160. Three days later, (A) cells were harvested and intracellular FoxP3 was stained as described in Fig. 1, (B) suppressive activities were determined as in Fig. 4 or (C) cell recovery were measured as described in Fig. 3 . Asterisks indicate a statistically significant difference (*P < 0.05, **P < 0.01) as compared with the mock controls. 
+ Treg cells also can be distinguished from conventional CD4 + T cells in that they are deficient in IL-2 production and anergic to TCR stimulation. However, this unresponsive state can be overridden by the addition of IL-2 (55, 68) (Fig. 3C) . The CD4 +
+ Treg cells suppress T cell proliferation by inhibiting IL-2 production in the target cells (52), and in agreement with these observations, the enhanced suppressive effect of CD4 + CD25 + Treg cells by HIV-1 binding correlated with their enhanced ability to suppress IL-2 production by target cells (Fig. 5B) .
Our data suggest that HIV gp120-CD4 interactions initiate the effects on Treg cells, since XLCD4 by anti-CD4 mAb plus GAM or plate-coated gp160, also induced increased FoxP3 expression, survival rate and suppressive activity of Treg cells. Addition of sCD4 blocked FoxP3 induction following HIV-1 exposure (Fig. 6) . Following HIV infection in vivo, the likelihood of CD4 engagement occurring is extremely high, since the relatively rare virus-producing cells are present in the lymphoid tissues in close proximity to large numbers of CD4
+ cells, and binding of cell surface-expressed gp120 will occur with surrounding cells (69) (70) (71) . However, in contrast to the report by Nilsson et al. (30) , in which engagement of CD4 by anti-CD4 antibody alone was enough to drive FoxP3 induction, we found that only XLCD4 by anti-CD4 plus GAM or plate-coated gp160, rather than CD4 engagement by mAb alone (data not shown), was necessary to drive these effects in Treg cells. Such CD4-gp120-dependent mechanisms also suggest that active virus replication in the effected cells seems not to be required. This hypothesis is also favored by our finding that UV-inactivated HIV-1 showed similar effects on Treg cells as live HIV-1 (Fig. 6A-C) . Of note, both the X4 strain HIV-1 213 and the R5 strain HIV-1 BaL caused increases in FoxP3 expression, survival rate and suppressive activity of Treg cells. Therefore, it appears that the mechanisms described here are not restricted to certain HIV-1 strains or limited by co-receptor involvement.
In numerous studies, it has been difficult to distinguish the relative contribution of loss of CD4 + cell numbers from loss of CD4 + T cell function for the progressive immunodeficiency that is characteristic of AIDS. FIV-infected cats do not suffer a dramatic loss of CD4 + cells until late in infection (72) , but any loss in CD4
+ cell numbers appears to more than offset by activation of suppressor function (73 
